Sofosbuvir & Velpatasvir is another hepatitis C direct-acting antiviral drug from the American company Gilead under the brand name Epclusa as the backbone. Patients with chronic hepatitis c must first undergo a systemic examination before taking Epclusa. Epclusa has little side effects but a high cure rate. Sofosbuvir & Velpatasvir is used in combination with ribavirin, another antiviral drug, to treat advanced liver cirrhosis. If you are thinking to save on Sofosbuvir & Velpatasvir, then you should choose generic. Read more- https://www.medixocentre.com/sofosbuvir-and-velpatasvir

Pomalyst contains the active substance pomalidomide. This medicine is related to thalidomide and belongs to a group of drugs that affect the immune system (the body's natural defense mechanisms). Pomalidomide is used to treat adults with a type of cancer called multiple myeloma. Pomalidomide in combination with dexamethasone is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior courses of treatment, including both lenalidomide and bortezomib, and who have had disease progression on the last treatment. https://www.medixocentre.com/pomalyst-pomalidomide-cost

Epclusa is a fixed-dose combination drug containing velpatasvir and sofosbuvir that can be used to treat hepatitis C (HCV) infection. Velpatasvir is a nucleotide analogue polymerase inhibitor and sofosbuvir is a pan-genotypic NS5A inhibitor. Epclusa contains velpatasvir and sofosbuvir. Velpatasvir works by interfering with a protein called HCV NS5A, which is required by the virus to reproduce itself. Epclusa ingredients initially significantly reduce and then completely stop the production of new copies of the hepatitis C virus. To know about Epclusa cost please visit- https://www.medixocentre.com/epclusa-cost